Journal of Cystic Fibrosis
Volume 9, Issue 4 , Pages 272-276 , July 2010

Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection

  • Marita Gilljam

      Affiliations

    • Department of Respiratory Medicine and Allergology, Bruna Stråket 11b, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46 31 3421000/+46 31 3427867; fax: +46 31824904.
  • ,
  • Henrik Scherstén

      Affiliations

    • Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
  • ,
  • Martin Silverborn

      Affiliations

    • Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
  • ,
  • Bodil Jönsson

      Affiliations

    • Department of Clinical Bacteriology, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
  • ,
  • Annika Ericsson Hollsing

      Affiliations

    • Department of Pediatrics, Uppsala Academic Hospital, SE 751 85 Uppsala, Sweden

Received 1 January 2010 ,Revised 14 March 2010 ,Accepted 15 March 2010.

References 

  1. Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis. Mar. 2008;14(3):378–384
  2. Petrini B. Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS. May 2006;114(5):319–328
  3. Sanguinetti M, Ardito F, Fiscarelli E, La Sorda M, D'Argenio P, Ricciotti G, et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol. Feb. 2001;39(2):816–819
  4. Taylor JL, Palmer SM. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. J Heart Lung Transplant. Aug. 2006;25(8):985–988
  5. Trulock EP, Bolman RM, Genton R. Pulmonary disease caused by Mycobacterium chelonae in a heart–lung transplant recipient with obliterative bronchiolitis. Am Rev Respir Dis. Sep. 1989;140(3):802–805
  6. Talati NJ, Rouphael N, Kuppalli K, Franco-Paredes C. Spectrum of CNS disease caused by rapidly growing mycobacteria. Lancet Infect Dis. Jun. 2008;8(6):390–398
  7. Malouf MA, Glanville AR. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med. Nov. 1999;160(5 Pt 1):1611–1616
  8. Morales P, Ros JA, Blanes M, Perez-Enguix D, Saiz V, Santos M. Successful recovery after disseminated infection due to mycobacterium abscessus in a lung transplant patient: subcutaneous nodule as first manifestation—a case report. Transplant Proc. Sep. 2007;39(7):2413–2415
  9. Chernenko SM, Humar A, Hutcheon M, Chow CW, Chaparro C, Keshavjee S, et al. Mycobacterium abscessus infections in lung transplant recipients: the international experience. J Heart Lung Transplant. Dec. 2006;25(12):1447–1455
  10. Chalermskulrat W, Sood N, Neuringer IP, Hecker TM, Chang L, Rivera MP, et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax. Jun. 2006;61(6):507–513
  11. Zaidi S, Elidemir O, Heinle JS, McKenzie ED, Schecter MG, Kaplan SL, et al. Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence. Transpl Infect Dis. Jun. 2009;11(3):243–248
  12. Jonsson BE, Gilljam M, Lindblad A, Ridell M, Wold AE, Welinder-Olsson C. Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J Clin Microbiol. May 2007;45(5):1497–1504
  13. Jordan PW, Stanley T, Donnelly FM, Elborn JS, McClurg RB, Millar BC, et al. Atypical mycobacterial infection in patients with cystic fibrosis: update on clinical microbiology methods. Lett Appl Microbiol. May 2007;44(5):459–466
  14. Catherinot E, Roux AL, Macheras E, Hubert D, Matmar M, Dannhoffer L, et al. Acute respiratory failure involving an R variant of Mycobacterium abscessus. J Clin Microbiol. Jan. 2009;47(1):271–274
  15. Haworth C, Bowden A, Elliot J, Barker H, Bilton D, Wat D, et al. Treatment of non-tuberculous mycobacteria in adults with cystic fibrosis. J Cyst Fibros. 2009;8:S46;[abstract]
  16. Robertson J, Elidemir O, Saz EU, Gulen F, Schecter M, McKenzie E, et al. Hypogammaglobulinemia: incidence, risk factors, and outcomes following pediatric lung transplantation. Pediatr Transplant. Sep. 2009;13(6):754–759

 This work has in part been presented at the 32nd European Cystic Fibrosis Conference, Brest, France, 2009.

PII: S1569-1993(10)00035-4

doi: 10.1016/j.jcf.2010.03.008

Journal of Cystic Fibrosis
Volume 9, Issue 4 , Pages 272-276 , July 2010